- Home
- JANX vs CTLP Comparison
JANX vs CTLP Comparison
Compare JANX & CTLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JANX | CTLP |
|---|---|---|
| Founded | 2017 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 798.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JANX | CTLP |
|---|---|---|
| Price | $13.59 | $10.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | ★ $52.45 | N/A |
| AVG Volume (30 Days) | 1.0M | ★ 1.5M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | N/A | $16.11 |
| Revenue Next Year | $235.70 | $14.37 |
| P/E Ratio | ★ N/A | $13.69 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $7.01 |
| 52 Week High | $35.34 | $11.16 |
Technical Indicators
Market Signals| Indicator | JANX | CTLP |
|---|---|---|
| Relative Strength Index (RSI) | 45.87 | 51.69 |
| Support Level | $13.03 | $9.82 |
| Resistance Level | $13.79 | $10.80 |
| Average True Range (ATR) | 0.50 | 0.24 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 55.56 | 85.35 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About CTLP Cantaloupe Inc.
Cantaloupe Inc is a technology leader powering self-service commerce by offering one integrated solution for payments processing, logistics, and back-office management. The group offers a comprehensive suite of solutions, including micro-payment processing, self-checkout kiosks, mobile ordering, connected point-of-sale (POS) systems, and enterprise cloud software. Its product and services portfolio consists of Card Readers, Self-Service Kiosks, Smart Coolers, Seed Pick Easy, Cantaloupe Go, Cheq, Smart Lock Connect, and Vine Digital Studio. The company derives revenue streams from subscriptions, transaction processing, and equipment sales.